Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > FDAnews Device Daily Bulletin > Ariosa Asks USPTO to Nix Sequenom Prenatal Test Patent

FDAnews Device Daily Bulletin

Sept. 20, 2012 | Vol. 9 No. 185

Ariosa Asks USPTO to Nix Sequenom Prenatal Test Patent

Ariosa Diagnostics Inc. filed a petition for inter partes review Monday asking the U.S. Patent and Trademark Office to invalidate a prenatal blood test patent that Sequenom Inc. accuses Ariosa of infringing.
Law360

Register Now
Print This Page
Email This Article
RSS
Archives

Related Articles

German Police Seize Nearly 200 Stents From Boston Scientific Corporation ALung Pursues Chinese Approval for Hemolung CRMC Patients May Have Received Insulin Pen Injection With Used Device Get Happy About Depression Study Results

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.